Search - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Access content directly

Filter your results

22 Results
Deposit type : Notice

Réforme de l’accès dérogatoire aux médicaments

Jacques-Olivier Bay
Bulletin du Cancer, 2022, 109 (1), pp.20-22. ⟨10.1016/j.bulcan.2021.11.008⟩
Journal articles hal-03737555v1

Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)

Jacques-Olivier Bay
Bone Marrow Transplantation, 2022, 57 (1), pp.125-127. ⟨10.1038/s41409-021-01477-6⟩
Journal articles hal-03737639v1

COVID-19 lockdown and mental health: why we must look into oncology units

Jacques-Olivier Bay
Psychological Medicine, 2022, 52 (4), pp.787-788. ⟨10.1017/S0033291720002500⟩
Journal articles hal-03737570v1

Response to vaccination against SARS‐CoV ‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study

Olivier Tournilhac
British Journal of Haematology, 2022, 197 (4), pp.424-427. ⟨10.1111/bjh.18055⟩
Journal articles hal-03737660v1

Impact du microenvironnement inflammatoire et de l'obésité dans la transition du cancer canalaire in situ (CCIS) en carcinome invasif (CCI) via le développement d’un modèle 3D de tumoroïdes fluorescents hétérogènes

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp , Cecile Garnier et al.
Journée jeunes chercheurs du réseau NACRE, Jun 2022, Paris, France
Conference papers hal-03853902v1

Applicability of the long‐term uncertainty in measurement ( LTUM ) method for analytical performance assessment in clinical cytometry laboratories

Marc Berger , Céline Bourgne
Cytometry Part B: Clinical Cytometry, 2022, 102 (3), pp.254-260. ⟨10.1002/cyto.b.22050⟩
Journal articles hal-03737689v1

ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

Camilla Lemvigh , Erin Michelle Parry , Stephanie Deng , Nathan Dangle , Neil Ruthen et al.
Blood, 2022, 140 (Supplement 1), pp.1807-1808. ⟨10.1182/blood-2022-162550⟩
Journal articles hal-03950370v1

Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia

Romain Guieze
Blood Advances, 2022, 6 (1), pp.207-211. ⟨10.1182/bloodadvances.2021006215⟩
Journal articles hal-03737676v1

Reduced telomere length in amniocytes: an early biomarker of abnormal fetal development?

Andrei Tchirkov , Véronèse Lauren
Human Molecular Genetics, 2022, ⟨10.1093/hmg/ddac054⟩
Journal articles hal-03737680v1

Obésité et progression tumorale : Optimisation d’un modèle 3D de tumoroïdes bicellulaires fluorescents mimant le cancer canalaire in situ dans un microenvironnement adipeux et inflammatoir

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp , Cecile Garnier et al.
Journées Francophones de Nutrition, Nov 2022, Toulouse, France
Conference poster hal-03854351v1

Practical approaches and optimization of a heterogeneous fluorescent tumoroid generation of ductal breast carcinoma in situ to study the impact of the adipose and inflammatory microenvironment

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp , Cecile Garnier et al.
32. annual conference of the European society for biomaterials, Sep 2022, Bordeaux, France
Conference poster hal-03856143v1

Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities—the TENALYS study, a patient perspective survey

Marc Berger
Orphanet Journal of Rare Diseases, 2022, 17 (1), pp.68. ⟨10.1186/s13023-022-02232-w⟩
Journal articles hal-03737534v1

Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

Julien Rossignol , Amani Ouedrani , Cristina Bulai Livideanu , Stéphane Barete , Louis Terriou et al.
The Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (5), pp.1356-1364.e2. ⟨10.1016/j.jaip.2021.12.038⟩
Journal articles pasteur-03697054v1

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma

Olivier Tournilhac
HemaSphere, 2022, 6 (2), pp.e675. ⟨10.1097/HS9.0000000000000675⟩
Journal articles hal-03737664v1

Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

Marc Berger
Cancer Research, 2022, 82 (6), pp.974-985. ⟨10.1158/0008-5472.CAN-20-4189⟩
Journal articles hal-03737527v1

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients

Benjamin Lebecque
Cancers, 2022, 14 (8), pp.1904. ⟨10.3390/cancers14081904⟩
Journal articles hal-03737692v1

2022, année de fictions certes, mais année de progrès

Jacques-Olivier Bay
Bulletin du Cancer, 2022, 109 (1), pp.1-2. ⟨10.1016/j.bulcan.2021.12.008⟩
Journal articles hal-03737581v1

Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Jacques-Olivier Bay
Journal of Cancer Research and Clinical Oncology, 2022, ⟨10.1007/s00432-022-04021-1⟩
Journal articles hal-03737646v1

Prévention de la transition du cancer mammaire in situ vers un cancer invasif chez les femmes en surpoids/obèses : développement d'un modèle de tumoroïdes bicellulaires fluorescents

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp , Cecile Garnier et al.
Assises régionales de Nutrition et Santé, Oct 2022, Clermont-Ferrand, France
Conference papers hal-03853875v1

Persistence of hepatitis E virus in the cerebrospinal fluid despite apparently successful ribavirin therapy

Jacques-Olivier Bay
Journal of Antimicrobial Chemotherapy, 2022, ⟨10.1093/jac/dkac147⟩
Journal articles hal-03737626v1

La recherche en cancérologie : la France face aux bouleversements géopolitiques et à son inégalité territoriale

Jacques-Olivier Bay
Bulletin du Cancer, 2022, 109 (3), pp.247-248. ⟨10.1016/j.bulcan.2022.02.001⟩
Journal articles hal-03737562v1

Développement d’un modèle 3D de tumoroïdes bicellulaires fluorescents mimant le cancer canalaire in situ dans un microenvironnement adipeux et inflammatoire

Laetitia Delort , Habanjar Ola , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp et al.
3èmes automnales du groupe Cancer Clermont Auvergne, Nov 2022, Clermont-Ferrand, France
Conference papers hal-03853577v1